Eli Lilly to Acquire Centessa Pharmaceuticals in a $6.3 Billion Deal
Eli Lilly and Company (LLY) entered a merger agreement on March 31, 2026, to acquire Centessa Pharmaceuticals plc (CNTA) in a deal valued at $6.3 billion. Deal Structure: Lilly…
Written byAsif SuriaSource: InsideArbitrage
Eli Lilly and Company (LLY) entered a merger agreement on March 31, 2026, to acquire Centessa Pharmaceuticals plc (CNTA) in a deal valued at $6.3 billion. Deal Structure: Lilly will acquire all of the share capital of Centessa (including the American Depositary Shares (ADSs) representing ordinary shares) for $38 in cash per share plus one